Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis
Clinical trial NCT06015113 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06015113
- Sponsor
- Xi'an International Medical Center Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2026-04-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.